Cargando…

Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection

Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Qiyang, Huang, Xuelin, Fang, Shenying, Guo, Shicheng, Liu, Yuanyuan, Lin, Wei, Xiong, Momiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759680/
https://www.ncbi.nlm.nih.gov/pubmed/33362849
http://dx.doi.org/10.3389/fgene.2020.585804
_version_ 1783627158053191680
author Ge, Qiyang
Huang, Xuelin
Fang, Shenying
Guo, Shicheng
Liu, Yuanyuan
Lin, Wei
Xiong, Momiao
author_facet Ge, Qiyang
Huang, Xuelin
Fang, Shenying
Guo, Shicheng
Liu, Yuanyuan
Lin, Wei
Xiong, Momiao
author_sort Ge, Qiyang
collection PubMed
description Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It can accurately estimate the individualized treatment effects and learn optimal treatment choices. Therefore, the AI approach can substantially improve progress and treatment outcomes of patients. One AI approach, conditional generative adversarial nets for inference of individualized treatment effects (GANITE) has been developed. However, GANITE can only deal with binary treatment and does not provide a tool for optimal treatment selection. To overcome these limitations, we modify conditional generative adversarial networks (MCGANs) to allow estimation of individualized effects of any types of treatments including binary, categorical and continuous treatments. We propose to use sparse techniques for selection of biomarkers that predict the best treatment for each patient. Simulations show that MCGANs outperform seven other state-of-the-art methods: linear regression (LR), Bayesian linear ridge regression (BLR), k-Nearest Neighbor (KNN), random forest classification [RF (C)], random forest regression [RF (R)], logistic regression (LogR), and support vector machine (SVM). To illustrate their applications, the proposed MCGANs were applied to 256 patients with newly diagnosed acute myeloid leukemia (AML) who were treated with high dose ara-C (HDAC), Idarubicin (IDA) and both of these two treatments (HDAC+IDA) at M. D. Anderson Cancer Center. Our results showed that MCGAN can more accurately and robustly estimate the individualized treatment effects than other state-of-the art methods. Several biomarkers such as GSK3, BILIRUBIN, SMAC are identified and a total of 30 biomarkers can explain 36.8% of treatment effect variation.
format Online
Article
Text
id pubmed-7759680
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77596802020-12-26 Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection Ge, Qiyang Huang, Xuelin Fang, Shenying Guo, Shicheng Liu, Yuanyuan Lin, Wei Xiong, Momiao Front Genet Genetics Treatment response is heterogeneous. However, the classical methods treat the treatment response as homogeneous and estimate the average treatment effects. The traditional methods are difficult to apply to precision oncology. Artificial intelligence (AI) is a powerful tool for precision oncology. It can accurately estimate the individualized treatment effects and learn optimal treatment choices. Therefore, the AI approach can substantially improve progress and treatment outcomes of patients. One AI approach, conditional generative adversarial nets for inference of individualized treatment effects (GANITE) has been developed. However, GANITE can only deal with binary treatment and does not provide a tool for optimal treatment selection. To overcome these limitations, we modify conditional generative adversarial networks (MCGANs) to allow estimation of individualized effects of any types of treatments including binary, categorical and continuous treatments. We propose to use sparse techniques for selection of biomarkers that predict the best treatment for each patient. Simulations show that MCGANs outperform seven other state-of-the-art methods: linear regression (LR), Bayesian linear ridge regression (BLR), k-Nearest Neighbor (KNN), random forest classification [RF (C)], random forest regression [RF (R)], logistic regression (LogR), and support vector machine (SVM). To illustrate their applications, the proposed MCGANs were applied to 256 patients with newly diagnosed acute myeloid leukemia (AML) who were treated with high dose ara-C (HDAC), Idarubicin (IDA) and both of these two treatments (HDAC+IDA) at M. D. Anderson Cancer Center. Our results showed that MCGAN can more accurately and robustly estimate the individualized treatment effects than other state-of-the art methods. Several biomarkers such as GSK3, BILIRUBIN, SMAC are identified and a total of 30 biomarkers can explain 36.8% of treatment effect variation. Frontiers Media S.A. 2020-12-11 /pmc/articles/PMC7759680/ /pubmed/33362849 http://dx.doi.org/10.3389/fgene.2020.585804 Text en Copyright © 2020 Ge, Huang, Fang, Guo, Liu, Lin and Xiong. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Ge, Qiyang
Huang, Xuelin
Fang, Shenying
Guo, Shicheng
Liu, Yuanyuan
Lin, Wei
Xiong, Momiao
Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title_full Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title_fullStr Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title_full_unstemmed Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title_short Conditional Generative Adversarial Networks for Individualized Treatment Effect Estimation and Treatment Selection
title_sort conditional generative adversarial networks for individualized treatment effect estimation and treatment selection
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759680/
https://www.ncbi.nlm.nih.gov/pubmed/33362849
http://dx.doi.org/10.3389/fgene.2020.585804
work_keys_str_mv AT geqiyang conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT huangxuelin conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT fangshenying conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT guoshicheng conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT liuyuanyuan conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT linwei conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection
AT xiongmomiao conditionalgenerativeadversarialnetworksforindividualizedtreatmenteffectestimationandtreatmentselection